The Claudius Regaud Institute is Toulouse's Cancer Centre. It forms a part of the UNICANCER Group, gathering the 20 French cancer centres and their federation (Federation française des Centres de lutte contre le cancer). It is a private institute of public interest.
The Institute was founded in 1923. Since then, doctors, researchers and treatment and administrative professionals specialised in cancer have worked together at the Institute. Today there are 800 people working at the Institute.
The Institute faces three key challenges: care, research and teaching. To effectively fight cancer, doctors and researchers from French cancer centres have, for over a century, been relying on a multidisciplinary approach: patients' records are discussed and studied during weekly meetings that bring together specialist doctors from different fields. Patients therefore benefit from a customised treatment program which is created by a team of specialists.
The Institute brings together all cancer related disciplines required to detect, treat and monitor the disease: surgery, medecine, radiotherapy, brachytherapy, nuclear medicine, imaging, biology and anatomical pathology.
Skills and technical means are grouped together on one site to ensure optimum case management. The latest advances related to diagnostics or treatment can therefore be rapidly implemented.
Since July 2010, the Claudius Regaud Institute has been certified without recommandation nor reservation by the Haute Autorité de Santé.
In 2014, the Claudius Regaud Institute will settle in the Institut universitaire du cancer, Toulouse Oncopole's hospital.